AEZS

Aeterna Zentaris (AEZS)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AEZS
DataOraFonteTitoloSimboloCompagnia
28/03/202412:55GlobeNewswire Inc.Ceapro Receives Final Court Approval for Merger with Aeterna ZentarisNASDAQ:AEZSAeterna Zentaris Inc
27/03/202413:05GlobeNewswire Inc.Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone DeficiencyNASDAQ:AEZSAeterna Zentaris Inc
12/03/202419:10GlobeNewswire Inc.Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special MeetingsNASDAQ:AEZSAeterna Zentaris Inc
26/02/202413:30GlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical CompanyNASDAQ:AEZSAeterna Zentaris Inc
15/02/202423:50GlobeNewswire Inc.Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with CeaproNASDAQ:AEZSAeterna Zentaris Inc
15/02/202422:54Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:AEZSAeterna Zentaris Inc
15/02/202415:33Edgar (US Regulatory)Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]NASDAQ:AEZSAeterna Zentaris Inc
22/12/202322:42Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:AEZSAeterna Zentaris Inc
14/12/202313:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
14/12/202313:50GlobeNewswire Inc.Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical CompanyNASDAQ:AEZSAeterna Zentaris Inc
09/11/202314:00GlobeNewswire Inc.Aeterna Zentaris Reports Third Quarter 2023 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
11/10/202314:00GlobeNewswire Inc.Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO ConferenceNASDAQ:AEZSAeterna Zentaris Inc
05/09/202314:00GlobeNewswire Inc.Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AEZSAeterna Zentaris Inc
09/08/202314:05GlobeNewswire Inc.Aeterna Zentaris Reports Second Quarter 2023 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
13/07/202313:30GlobeNewswire Inc.Aeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate UpdateNASDAQ:AEZSAeterna Zentaris Inc
05/07/202314:45GlobeNewswire Inc.Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight SeriesNASDAQ:AEZSAeterna Zentaris Inc
14/06/202322:43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AEZSAeterna Zentaris Inc
14/06/202322:05GlobeNewswire Inc.Aeterna Zentaris Announces Results of Virtual 2023 Meeting of ShareholdersNASDAQ:AEZSAeterna Zentaris Inc
15/05/202322:05GlobeNewswire Inc.Aeterna Zentaris Announces Virtual 2023 Meeting of ShareholdersNASDAQ:AEZSAeterna Zentaris Inc
11/05/202312:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AEZSAeterna Zentaris Inc
09/05/202323:00GlobeNewswire Inc.Aeterna Zentaris Reports First Quarter 2023 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
05/04/202313:55GlobeNewswire Inc.Aeterna Zentaris Provides Update on Macrilen® (Macimorelin), Reiterates Advancement of Pediatric DETECT TrialNASDAQ:AEZSAeterna Zentaris Inc
23/03/202313:08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:AEZSAeterna Zentaris Inc
23/03/202313:05GlobeNewswire Inc.Aeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
16/03/202313:05GlobeNewswire Inc.Pharmanovia to Market GHRYVELIN™ (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD)NASDAQ:AEZSAeterna Zentaris Inc
17/01/202314:05GlobeNewswire Inc.Aeterna Zentaris Provides Business Update and Outlines Key Upcoming MilestonesNASDAQ:AEZSAeterna Zentaris Inc
10/01/202314:05GlobeNewswire Inc.Aeterna Zentaris to Present at the Virtual Investor 2023 Companies to Watch EventNASDAQ:AEZSAeterna Zentaris Inc
03/11/202213:05GlobeNewswire Inc.Aeterna Zentaris Reports Third Quarter 2022 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
06/09/202212:15TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Aeterna Zentaris (AEZS)NASDAQ:AEZSAeterna Zentaris Inc
29/08/202214:00GlobeNewswire Inc.Aeterna Zentaris Set to Regain Full Rights to Macrilen™ (Macimorelin) in U.S. and Canada from Novo NordiskNASDAQ:AEZSAeterna Zentaris Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AEZS
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network